Enhanced tumor growth caused by constitutive activation of Akt in PTEN (-/-) cells also was reversed by CCI-779 (rapamycin derivative) treatment, indicating that mTOR functions downstream of Akt in tumorigenesis [370]. Here, AKT1 is linked to neoplasm.